These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24127777)

  • 41. Drug discovery with DNA-encoded chemical libraries.
    Buller F; Mannocci L; Scheuermann J; Neri D
    Bioconjug Chem; 2010 Sep; 21(9):1571-80. PubMed ID: 20681509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of surface groups on poly(propylene imine) dendrimers antiprion activity.
    McCarthy JM; Rasines Moreno B; Filippini D; Komber H; Maly M; Cernescu M; Brutschy B; Appelhans D; Rogers MS
    Biomacromolecules; 2013 Jan; 14(1):27-37. PubMed ID: 23234313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.
    Arkin MR; Tang Y; Wells JA
    Chem Biol; 2014 Sep; 21(9):1102-14. PubMed ID: 25237857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors.
    Kolb P; Kipouros CB; Huang D; Caflisch A
    Proteins; 2008 Oct; 73(1):11-8. PubMed ID: 18384152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV-1 X4 activities of polycationic "viologen" based dendrimers by interaction with the chemokine receptor CXCR4: study of structure-activity relationship.
    Asaftei S; Huskens D; Schols D
    J Med Chem; 2012 Dec; 55(23):10405-13. PubMed ID: 23157587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-based design of HSPA5 inhibitors: from peptide to small molecule inhibitors.
    Huang M; Li Z; Li D; Walker S; Greenan C; Kennedy R
    Bioorg Med Chem Lett; 2013 May; 23(10):3044-50. PubMed ID: 23562057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular insight into specific 14-3-3 modulators: Inhibitors and stabilisers of protein-protein interactions of 14-3-3.
    Hartman AM; Hirsch AKH
    Eur J Med Chem; 2017 Aug; 136():573-584. PubMed ID: 28549334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expanding the medicinally relevant chemical space with compound libraries.
    López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
    Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Small-molecule PARP modulators--current status and future therapeutic potential.
    Penning TD
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):577-86. PubMed ID: 20812149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
    Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
    J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficient search of chemical space: navigating from fragments to structurally diverse chemotypes.
    Wassermann AM; Kutchukian PS; Lounkine E; Luethi T; Hamon J; Bocker MT; Malik HA; Cowan-Jacob SW; Glick M
    J Med Chem; 2013 Nov; 56(21):8879-91. PubMed ID: 24117015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemical informatics: using molecular shape descriptors in structure-based drug design.
    Jennings A
    Methods Mol Biol; 2012; 841():235-50. PubMed ID: 22222455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small-molecule procaspase activators identified using fluorescence polarization.
    Vickers CJ; González-Páez GE; Umotoy JC; Cayanan-Garrett C; Brown SJ; Wolan DW
    Chembiochem; 2013 Aug; 14(12):1419-22. PubMed ID: 23836614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
    Hennig M; Ruf A; Huber W
    Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multivalent choline dendrimers as potent inhibitors of pneumococcal cell-wall hydrolysis.
    Hernández-Rocamora VM; Maestro B; de Waal B; Morales M; García P; Meijer EW; Merkx M; Sanz JM
    Angew Chem Int Ed Engl; 2009; 48(5):948-51. PubMed ID: 19115336
    [No Abstract]   [Full Text] [Related]  

  • 56. Structural aspects of small-molecule inhibition of methyllysine reader proteins.
    Milosevich N; Warmerdam Z; Hof F
    Future Med Chem; 2016 Sep; 8(13):1681-702. PubMed ID: 27577975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
    Fauman EB; Rai BK; Huang ES
    Curr Opin Chem Biol; 2011 Aug; 15(4):463-8. PubMed ID: 21704549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions.
    Huang RR; Dehaven RN; Cheung AH; Diehl RE; Dixon RA; Strader CD
    Mol Pharmacol; 1990 Feb; 37(2):304-10. PubMed ID: 2154676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fragment-based ligand discovery.
    Fischer M; Hubbard RE
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dendrimers as potential inhibitors of the dimerization of the capsid protein of HIV-1.
    Doménech R; Abian O; Bocanegra R; Correa J; Sousa-Herves A; Riguera R; Mateu MG; Fernandez-Megia E; Velázquez-Campoy A; Neira JL
    Biomacromolecules; 2010 Aug; 11(8):2069-78. PubMed ID: 20690715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.